Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal Cancer
Sponsor
Protgen Ltd (Industry)
Overall Status
Unknown status
CT.gov ID
NCT02324114
Collaborator
(none)
1,100
1
1
27
40.8
Study Details
Study Description
Brief Summary
Detect plasma Hsp90α concentration of colorectal cancer patients, healthy volunteers, benign colorectal diseases patients.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Detect plasma Hsp90α concentration of colorectal cancer patients, healthy volunteers, benign colorectal diseases patients, validate accuracy, specificity and sensitivity of Hsp90α kit.
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
1100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal Cancer
Study Start Date
:
Sep 1, 2012
Anticipated Primary Completion Date
:
Dec 1, 2014
Anticipated Study Completion Date
:
Dec 1, 2014
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Rectal cancer Detect plasma Hsp90α concentration of patients, |
Device: Hsp90
Detect plasma Hsp90α concentration
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Hsp90α Concentration(ng/ml) of plasma [4 months]
Detect Hsp90α Concentration(ng/ml) of plasma and calculate the accuracy, specificity and sensitivity of Hsp90α kit
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- colorectal cancer patients, healthy volunteers, benign colorectal diseases patients
Exclusion Criteria:
- Patients who previously accepted radiotherapy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Shandong province cancer hospital | Jinan | Shandong | China |
Sponsors and Collaborators
- Protgen Ltd
Investigators
- Principal Investigator: Jinming Yu, MD, Shandong province cancer hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Protgen Ltd
ClinicalTrials.gov Identifier:
NCT02324114
Other Study ID Numbers:
- hsp90a2011-03
First Posted:
Dec 24, 2014
Last Update Posted:
Dec 24, 2014
Last Verified:
Dec 1, 2014